Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...

While Zika has been reported in more than 90 countries, surprisingly little is known about what exactly drives Zika ...

Data on flu test positivity and Tamiflu prescription fills show that influenza activity has already surpassed the past 7 ...

The newer variant of avian influenza that recently infected dairy cattle in Nevada has a genetic change that’s thought to ...

Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.

This version of the virus is circulating broadly in wild birds and is different from the virus that has been causing dairy ...

University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of Herpes Simplex Viruses post infection. TORONTO, ON / ACCESS Newswire / Febru ...

Cidara Therapeutics is leveraging its Cloudbreak platform to develop CD388 for universal influenza prophylaxis. See why I ...

Clinical-stage pharma stock Theralase Technologies (TSXV:TLT) announced a significant breakthrough in the treatment of Herpes ...

The new junior research group Viral Systems Modeling headed by Dr. Tanja Laske started work at the Leibniz Institute of Virology (LIV) on February 1, 2025. The group is dedicated to computer-assisted ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.